Milrinone Drug: Indication, Dosage, Precaution, Side Effect , Storage, Category Type and corresponding Brands - www.genericdrugscan.com
Milrinone
Drug Status in USA : ApprovedDrug Status in Canada : Approved
Indication : Why is this medication prescribed?
Short-term management of CCF in patients unresponsive to digitalis, diuretics or vasodilators.Contraindication: What are the special precautions to be followed?
Under following conditions, use of this medication is inadvisable. Its use should be withhold as it would cause harm to the patientHypersensitivity. Heart valve stenosis, acute myocardial infarction.
Other Precaution to be observed while taking this medication
Monitor fluid and electrolyte balance. Do not use in patients with severe obstructive aortic or pulmonic valvular disease. Hypertrophic cardiomyopathy, atrial flutter or fibrillation. Pregnancy and lactation.What are possible side effects of this medication ?
Headache, hypokalaemia, tremors, ventricular arrhythmias (including ventricular ectopic activity, hypotension nonsustained/sustained ventricular tachycardia, angina, ventricular fibrillation.)Drug Category/Class
- Platelet Aggregation Inhibitors
- Phosphodiesterase Inhibitors
- Cardiotonic Agents
- Phosphodiesterase 3 Inhibitors
- Vasodilator Agents
- Cardiovascular System
- Cardiac Therapy
- Cardiac Stimulants Excl. Cardiac Glycosides
- Phosphodiesterase inhibitors
| Prescribed | Indicated for the treatment of congestive heart failure. |
| Weight : | 211.2194 |
| Structure | Milrinone |
 | |
| Formula | C12H9N3O |
Milrinone has 6 Brands listed
| Milicor (10 mg) | Milrineon (10 mg) |
| Mirisol (10 mg) | Myolong (10 mg) |
| Primacor (10 mg) | Primacor IV (10 mg) |